Mindray's New TE7 Max Ultrasound System Expands Possibilities for Point of Care
|
By MedImaging International staff writers Posted on 27 Oct 2021 |
|
Mindray North America (Mahwah, NJ, USA) has launched its new TE7 Max ultrasound system that maximizes the potential of ultrasound in the Point of Care (POC) market.
The TE7 Max has a 21.5 inch vertically oriented high-definition LED display and a sealed touch-based interface to maximize what clinicians can see. Designed to exceed the requirements of demanding POC environments, the system provides best-in-class image quality and a superior user experience during rapid clinical assessments and procedures. Unlike traditional POC ultrasound machines (POCUS), the TE7 Max provides clinicians with comprehensive and customizable workflow protocols (iWorks™) and an extensive suite of artificial intelligence (AI) powered Smart Tools, all in a compact footprint so they can quickly move from patient-to-patient prioritizing efficiency, reproducibility, and quality for all end-users.
Using AI-powered Smart Tools (Smart B-Line, Smart VTI, Smart IVC), the portable ultrasound system can help assess volume status and fluid responsiveness in critically ill patients. With advanced applications (Smart FHR, Smart Bladder, Auto EF), the TE7 Max can help clinicians during rapid clinical assessments and procedures at patients' bedside or on the go. It is also equipped with the most advanced suite of needle-guidance technologies (eSpacial Navi™ 4D Magnetic Needle Navigation Technology and iNeedle+™) to help streamline workflow and improve accuracy with needle-guided procedures.
The slim cart and large screen beautifully display Mindray's leading-edge technologies and everyday applications that meet the diverse, evolving demands of POC environments. Additionally, the TE7 Max ultrasound machine is backed by Mindray's exclusive Living Technology™ promise that provides customers with easily upgradable software enhancements to secure product investment protection and keep their ultrasound machines at the leading edge of imaging performance excellence throughout the product's life cycle.
"Five years ago, Mindray set a new standard for Point of Care ultrasound with the launch of the TE7," said Maher Elhihi, Mindray's Sr. Director of Marketing, Ultrasound. "That system was truly ahead of its time, and today many of our competitors have tried to emulate. As a leader in Emergency Medicine ultrasound, it is our responsibility to push the technology forward, and the new TE7 Max raises the bar yet again and empowers our customers to provide the highest quality of care now and in the future."
Related Links:
Mindray North America
Latest Ultrasound News
- Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
- Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
- AI Ultrasound Platform Receives CE Mark for Prenatal Screening
- Hybrid Imaging Platform Reveals How Sleep Supports Brain Waste Removal
- AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
- Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Channels
Radiography
view channel
Computational X-Ray Technique Enables High-Resolution, Low-Dose Radiography
Reducing radiation in medical X-ray imaging remains a persistent challenge because dose reductions often degrade spatial resolution and diagnostic confidence. This is especially critical in pediatrics,... Read more
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
MRI
view channel
Advanced MRI Reveals Structural Brain Changes Linked to Better Cognitive Health
Objective, noninvasive measures that capture subtle, training-related changes in adult brain structure remain limited in routine clinical practice. Quantifying neuroplasticity with precision is especially... Read more
Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
Myocardial infarction often leaves patients with persistent ventricular dysfunction that can progress without obvious signs. Detecting early decline remains difficult because standard measures may miss... Read more
Nuclear Medicine
view channel
Radiotherapy Professionals Embrace AI as a Clinical Support Tool
Radiotherapy planning requires precise identification of organs at risk near a tumor, but manual contouring is repetitive and time-consuming, often delaying plan completion and straining specialist capacity.... Read more
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read more
![Image: (A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within 7 days. (D) Multimodal imaging evaluation of patient 3, including X-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT. (Photo courtesy of SNMMI)](https://globetechcdn.com/mobile_medicalimaging/images/stories/articles/article_images/2026-06-07/294811110_image_1.jpg "Image: (A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within 7 days. (D) Multimodal imaging evaluation of patient 3, including X-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT. (Photo courtesy of SNMMI)")
General/Advanced Imaging
view channel
New PE-RADS Framework Standardizes Pulmonary Embolism Imaging Reports
Pulmonary embolism is a sudden blockage of the lung’s blood vessels that reduces pulmonary blood flow, can strain the right hear,t and may be fatal if untreated. Patients often present with shortness of... Read more
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
Industry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more
